Trump’s ‘Most Favoured Nation’ drug policy could reshape trade with Indian pharma

InternationalIANS
Advertisement
Washington, Dec 18, : US President Donald Trump’s announcement of sweeping prescription drug price cuts under a “Most Favoured Nation” policy has put India’s pharmaceutical industry in focus, as Washington moves to benchmark US drug prices against those paid in other countries.

In an address to the nation on Wednesday (local time), Trump said his administration had negotiated sharp reductions in drug prices by directly confronting pharmaceutical companies and foreign governments, using trade pressure to force changes in global pricing.

“I negotiated directly with the drug companies and foreign nations, which were taking advantage of our country for many decades to slash prices on drugs and pharmaceuticals by as much as 400, 500, and even 600 per cent,” Trump said.

He said the policy, known as “Most Favoured Nation,” would reverse decades of rising drug costs in the United States.

“There has never been anything like this in the history of our country,” Trump said, adding that drug prices “have only gone up, but now they’ll be going down by numbers never conceived possible.”

Trump said the first round of price reductions would take effect in January and be available through a new government website, TrumpRx.gov.

Notably, Indian pharmaceutical companies play a central role in supplying low-cost drugs to American consumers and are deeply integrated into US healthcare supply chains.

Trump said he used the “threat of tariffs” to pressure foreign countries to absorb part of the cost of lowering US drug prices.

“I used the threat of tariffs to get foreign countries who would never have done it to pay the cost of this giant dollar reduction,” he said.

The remarks suggest trade tools could be used alongside healthcare policy, potentially reshaping how drug prices are negotiated internationally and how exporters engage with the US market.

Trump also criticised health insurance companies, saying they had become rich on money that “should go directly to the people,” and argued that lower drug prices would sharply reduce healthcare costs for American families.

“These big price cuts will greatly reduce the cost of healthcare,” he said.

For Indian drugmakers, the key question will be how the Most Favoured Nation model is implemented and whether pricing pressure falls primarily on branded drugs, generics, or both.

Indian firms supply a large share of off-patent medicines in the US and have invested heavily in facilities meeting US regulatory standards.

Trump’s renewed push revives an issue he raised repeatedly during his first term, when he argued that Americans were subsidising lower drug prices abroad and called for international price parity.

As Trump moves to reset US healthcare pricing, Indian pharma faces the challenge of absorbing pricing pressure while maintaining its role as a cornerstone of affordable medicine supply to the United States.

Advertisement

Note: The content of this article is sourced from a news agency and has not been edited by the ap7am team.

Donald TrumpMost Favoured Nationdrug pricingIndian pharmapharmaceutical industryUS healthcaredrug price cutsTrumpRx.govtrade tariffsgeneric drugs

More News

Telangana’s 4,000 MW Yadadri plant to achieve full capacity soon

17 Nov, 19:01

Reports of unwanted Instagram recommendations in India halved over past year: Meta

17 Nov, 19:00

Trump watches as PM Modi picks up Indian flag marker from floor, video goes viral

17 Nov, 18:58

Rajinikanth's daughter Soundarya shares pictures of their family getaway in Greece; says 'What amazing memories we’ve made in Athens!'

17 Nov, 18:56

When Jackie Shroff gave 10x returns to Archana Puran Singh on pending principal amount from struggling days

17 Nov, 18:54

'There was no one like Dhoni, and can't see anyone in next 10 years either': Coach MP Singh

17 Nov, 18:53

Dulquer Salmaan's 'Aakasamlo Oka Tara' cleared for release with U/A certificate

17 Nov, 18:52

Gas leak from ONGC well in Andhra brought under control

17 Nov, 18:50

‘Learned the meaning of simplicity…’: Ruturaj Gaikwad’s heartfelt tribute to Dhoni

17 Nov, 18:49

Dhanush, Mammootty-starrer 'Om' cleared for release with U/A certificate!

17 Nov, 18:47

Sri Lanka lose 15 WTC points, Pakistan docked five for slow over-rate during Rawalpindi Test

17 Nov, 18:46

'IPL will not be the same': Cricket fraternity pays emotional tribute to MS Dhoni after retirement

17 Nov, 18:44

Rahul Gandhi responds to backlash over 'lap' remark, shares temple sculpture

17 Nov, 18:43

PM Modi is 'a very tough man': Trump after meeting Quad counterparts

17 Nov, 17:06

Drug cartels turn to private players, DIY videos to evade crackdown; agencies flag new trend

17 Nov, 17:05

Gurnoor Brar reprimanded for Code of Conduct breach, handed one demerit point

17 Nov, 17:03

Why did Telangana find no mention in Sonia Gandhi’s book: BRS

17 Nov, 17:02

MS Dhoni’s IPL legacy: Five titles, 5,439 runs and several records

17 Nov, 16:57

Nifty hits 9-month high, Bank Nifty scales record peak as market rally extends

17 Nov, 16:00

Dhoni quietly said, ‘Maybe you should add my name' in release list, reveals CSK owner Rupa Gurunath

17 Nov, 15:46
..More News